Helicobacter pylori eradication therapy
Sponsors
Soichiro Sue, Sue Soichiro, University of Malaya, Seoul National University Hospital, Mashhad University of Medical Sciences
Conditions
Gastrointestinal DiseaseHELICOBACTER PYLORI INFECTIONSHelicobacter Pylori InfectionHelicobacter pylori eradication therapy
Helicobacter pyloriHelicobacter pylori infection
Helicobacter pyloriParkinson's DiseaseResistant Infection
Phase 2
VAS third-line eradication study
Active, not recruitingJPRN-jRCTs031190031
Start: 2019-06-17Target: 68Updated: 2026-06-29
RCT of Vonoprazan and high dose Amoxicillin eradication
RecruitingJPRN-jRCTs031200128
Start: 2020-11-04Target: 120Updated: 2026-06-29
H. pylori rescue eradication therapy with lascufloxacin, amoxicillin, and vonoprazan
Active, not recruitingJPRN-jRCTs031200154
Start: 2020-11-18Target: 23Updated: 2026-06-29
VCM eradication therapy for penicillin allergy
Active, not recruitingJPRN-jRCTs031200171
Start: 2020-12-02Target: 30Updated: 2026-06-29
Helicobacter pylori eradication therapy with Vonoprazan, reduced dosage of amoxicillin, and clarithromycin for hemodialysis patients
RecruitingJPRN-jRCTs031200237
Start: 2023-05-12Target: 23Updated: 2026-06-29
Helicobacter pylori eradication therapy with vonoprazan, clarithromycin, and metronidazole for chronic kidney disease patients
RecruitingJPRN-jRCTs031200239
Start: 2021-02-01Target: 24Updated: 2026-06-29
H. pylori rescue eradication therapy with rifabutin, metronidazole, and vonoprazan
Active, not recruitingJPRN-jRCTs031220504
Start: 2023-01-18Target: 20Updated: 2026-06-29
H. pylori rescue eradication therapy with rifabutin, sitafloxacin, and vonoprazan
Active, not recruitingJPRN-jRCTs031230735
Start: 2024-04-10Target: 40Updated: 2026-06-29
Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients
CompletedNCT06973889
Start: 2023-12-04End: 2025-01-21Updated: 2025-05-15